207
Views
2
CrossRef citations to date
0
Altmetric
Research Aricles

Mast cells and M2 macrophages in ovarian cancer

, , , & ORCID Icon

References

  • Ammendola M, Sacco R, Sammarco G, Donato G, Zuccalà V, Luposella M, et al. 2014. Mast cells density positive to tryptase correlates with angiogenesis in pancreatic ductal adenocarcinoma patients having undergone surgery. Gastroenterology Research and Practice 2014:951957.
  • An Y, Yang Q. 2020. Development and validation of an immune-related prognostic signature for ovarian cancer based on weighted gene coexpression network analysis. BioMed Research International 2020:7594098.
  • Arango HG. 2001. Bioestatística teórica e computacional. Rio de Janeiro: Guanabara Koogan; p. 93–113.
  • Chan JK, Magistris A, Loizzi V, Lin F, Rutgers J, Osann K, et al. 2005. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Gynecologic Oncology 99:20–25.
  • Ch'ng S, Wallis RA, Yuan L, Davis PF, Tan ST. 2006. Mast cells and cutaneous malignancies. Modern Pathology 19:149–159.
  • Colvin EK. 2014. Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Frontiers in Oncology 4:137.
  • Corvigno S, Wisman GB, Mezheyeuski A, van der Zee AG, Nijman HW, Åvall-Lundqvist E, et al. 2016. Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: inter- and intra-patient heterogeneity and impact on survival. Oncotarget 7:18573–18584.
  • El-Arabey AA, Abdalla M. 2021. GATA3 as a regulator for naughty cancer-associated fibroblasts in the microenvironment of high-grade serous ovarian cancer. Human Cell 34:1934–1936.
  • El-Arabey AA, Abdalla M, Abd-Allah AR. 2020. GATA3 and stemness of high-grade serous ovarian carcinoma: novel hope for the deadliest type of ovarian cancer. Human Cell 33:904–906.
  • El-Arabey AA, Abdalla M, Abd-Allah AR. 2021. Ovarian cancer immunotherapy of NF-κB may have a dark side. Human Cell 34:1019–1020.
  • El-Arabey AA, Denizli M, Kanlikilicer P, Bayraktar R, Ivan C, Rashed M, et al. 2020. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma. Cellular Signalling 68:109539.
  • Elpek GO, Gelen T, Aksoy NH, Erdoğan A, Dertsiz L, Demircan A, et al. 2001. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. Journal of Clinical Pathology 54:940–944.
  • Eo WK, Kim KH, Park EJ, Kim HY, Kim HB, Koh SB, et al. 2018. Diagnostic accuracy of inflammatory markers for distinguishing malignant and benign ovarian masses. Journal of Cancer 9:1165–1172.
  • Goswami KK, Ghosh T, Ghosh S, Sarkar M, Bose A, Baral R. 2017. Tumor promoting role of anti-tumor macrophages in tumor microenvironment. Cellular Immunology 316:1–10.
  • Jackute J, Zemaitis M, Pranys D, Sitkauskiene B, Miliauskas S, Vaitkiene S, et al. 2018. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer. BMC Immunology 19:3.
  • Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, et al. 2011. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. The Journal of Surgical Research 167:e211–9–e219.
  • Lanciotti M, Masieri L, Raspollini MR, Minervini A, Mari A, Comito G, et al. 2014. The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy. BioMed Research International 2014:486798.
  • Lee CC, Liu KJ, Huang TS. 2006. Tumor-associated macrophage: its role in tumor angiogenesis. Journal of Molecular Cancer 2:135–140.
  • Loughran EA, Leonard AK, Hilliard TS, Phan RC, Yemc MG, Harper E, et al. 2018. Aging increases susceptibility to ovarian cancer metastasis in murine allograft models and alters immune composition of peritoneal adipose tissue. Neoplasia 20:621–631.
  • Matsushita N, Ghazizadeh M, Konishi H, Araki T. 2003. Association of ovarian tumor epithelium coexpressing HLA-DR and CA-125 antigens with tumor infiltrating cytotoxic T lymphocytes. Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi 70:40–44.
  • Mhawech-Fauceglia P, Wang D, Ali L, Lele S, Huba MA, Liu S, et al. 2013. Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients. Cancer Immunity 13:1.
  • Murta EF, da Silva CS, Gomes RA, Tavares-Murta BM, Melo AL. 2004. Ultrasonographic criteria and tumor marker assay are good procedures for the diagnosis of ovarian neoplasia in preselected outpatients. European Journal of Gynaecological Oncology 25:707–712.
  • Murta EF, Nomelini RS. 2006. Early diagnosis and predictors of malignancy of adnexal masses. Current Opinion in Obstetrics & Gynecology 18:14–19.
  • Nowak M, Klink M. 2020. The role of tumor-associated macrophages in the progression and chemoresistance of ovarian cancer. Cells 9:1299.
  • Noy R, Pollard JW. 2014. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41:49–61.
  • Ostman A, Augsten M. 2009. Cancer-associated fibroblasts and tumor growth–bystanders turning into key players. Current Opinion in Genetics & Development 19:67–73.
  • Pansrikaew P, Cheewakriangkrai C, Taweevisit M, Khunamornpong S, Siriaunkgul S. 2010. Correlation of mast cell density, tumor angiogenesis, and clinical outcomes in patients with endometrioid endometrial cancer. Asian Pacific Journal of Cancer Prevention 11:623–626.
  • Parizi ACG, Barbosa RL, Parizi JLS, Nai GA. 2010. A comparison between the concentration of mast cells in squamous cell carcinomas of the skin and oral cavity. Anais Brasileiros de Dermatologia 85:811–818.
  • Ribatti D, Vacca A, Marzullo A, Nico B, Ria R, Roncali L, et al. 2000. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. International Journal of Cancer 85:171–175.
  • Sica A, Saccani A, Mantovani A. 2002. Tumor-associated macrophages: a molecular perspective. International Immunopharmacology 2:1045–1054.
  • Solinas G, Germano G, Mantovani A, Allavena P. 2009. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. Journal of Leukocyte Biology 86:1065–1073.
  • Torisu H, Ono M, Kiryu H, Furue M, Ohmoto Y, Nakayama J, et al. 2000. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. International Journal of Cancer 85:182–188.
  • Wang X, Zhao X, Wang K, Wu L, Duan T. 2013. Interaction of monocytes/macrophages with ovarian cancer cells promotes angiogenesis in vitro. Cancer Science 104:516–523.
  • Zeppernick F, Meinhold-Heerlein I. 2014. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer. Archives of Gynecology and Obstetrics 290:839–842.
  • Zhang M, Yifeng H, Xiangjun S, Qing L, Wenjing W, Aimin Z, et al. 2014. A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients. Journal of Ovarian Research 7:19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.